DEVERSIFY AB STRENGTHENS BOARD OF DIRECTORS AND THE ORGANISATION
Deversify AB strengthens its board of directors with Tabitha Hayes and Johan Lund, as well as the organisation with Jessica Roxhed and Sara Lindgren.
Deversify AB has this May successfully completed a rights issue, raising proceeds of SEK 11,2 million (USD 1,5 million). The net cash from the rights issue will be used to continue building and strengthening the organisation and to support the company’s commercial strategy.
”With a successful rights issue completed we are now focusing on our commercial expansion and have strengthened the expertise of the board of directors. I am delighted to announce Tabitha Hayes and Johan Lund as new Directors of the board. Tabitha has an extensive background in international project management and marketing and Johan has a substantial financial background with a focus on fundraising and mergers and acquisitions. These are two experienced and highly competent professionals that will contribute greatly to our continuous development”, says Åsa Lang Chairman of the board and Co-Founder.
”This spring we are entering a new phase focused on implementation and we are building an organisation fit for the future. We will stand strong and well-equipped to achieve our prioritisations”, says CEO and Co-Founder Anders Murman. “Jessica Roxhed with valuable CFO and controller experience strengthens the organisation and its financial expertise as our new CFO and is a welcome step towards a future IPO. Sara Lindgren is a key resource for our accelerating expansion and commercialisation of Acetrack in Europe”.
Deversify’s first product Acetrack allows you to measure your fat burning rate in real time –everything to improve the understanding of individual metabolism.
About Deversify:
Deversify is a Swedish R&D company offering tech solutions in consumer health. We develop and commercialize mobile electronic devices and apps to monitor biomarkers for individualized health. Our products help people understand — and improve — their own health. Our mission is to act as a good force against today’s lifestyle diseases – such as obesity, diabetes, addictions, and cardiovascular disease. Deversify operates in growing consumer health markets which today in Europe and US alone are valued at over USD 5 billion. Our first product, the ketone breathalyzer Acetrack®️, measures if your body is burning fat and is currently sold to health-tech consumers. Deversify is here to help you understand your wellbeing holistically – inside and out, from ketones to ECG.
Contact:
Anders Murman, CEO
anders.murman@deversify.com
+46 70 546 50 62
deversify.com
getacetrack.com
Relaterade länkar
Ämnen
Ekonomi, finans Vetenskap, teknik Data, Telekom, IT Företagande Hälsa, sjukvård, läkemedel
Kategorier
e-hälsa financing finansiering startup deversify IPO medtech mobile-health
Anders Murman
PRESSKONTAKT
Founder & CEO
anders.murman@deversify.com
+46705465062
Sara Lindgren
PRESSKONTAKT
CMO
sara.lindgren@deversify.com
00447771774014
Om Deversify:
Deversify är ett svenskt R&D-företag som erbjuder tekniska lösningar inom området konsumenthälsa. Vi utvecklar och kommersialiserar mobila, elektroniska enheter och appar för mätning av biomarkörer för individuell hälsostatus. Våra produkter hjälper människor att förstå – och att förbättra – sin egen hälsa. Vårt uppdrag är att verka som en god motkraft mot dagens livsstilssjukdomar såsom övervikt, diabetes, beroendesjukdomar och hjärt- och kärlsjukdomar. Deversify fokuserar på växande konsumentmarknader som idag inom hälsoområdet värderas till över 50 miljarder SEK enbart i Europa och USA. Vår flaggskeppsprodukt, utandningsmätaren Acetrack®️, mäter om din kropp är i fettförbränningsläge och säljs till health tech-användare. Deversify är här för att hjälpa dig förstå din egen hälsa holistiskt – inifrån och ut – från ketoner till EKG.
About Deversify:
Deversify is a Swedish R&D company offering tech solutions in consumer health. We develop and commercialize mobile electronic devices and apps to monitor biomarkers for individualized health. Our products help people understand — and improve — their own health. Our mission is to act as a good force against today’s lifestyle diseases – such as obesity, diabetes, addictions, and cardiovascular disease. Deversify operates in growing consumer health markets which today in Europe and US alone are valued at over USD 5 billion. Our first product, the ketone breathalyzer Acetrack®️, measures if your body is burning fat and is currently sold to health-tech consumers. Deversify is here to help you understand your wellbeing holistically – inside and out, from ketones to ECG.
Tags:
